190 related articles for article (PubMed ID: 21704134)
1. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study.
Ibrahim L; Duncan W; Luckenbaugh DA; Yuan P; Machado-Vieira R; Zarate CA
Brain Res Bull; 2011 Aug; 86(1-2):129-33. PubMed ID: 21704134
[TBL] [Abstract][Full Text] [Related]
2. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic factors in depression in response to treatment.
Buttenschøn HN; Foldager L; Elfving B; Poulsen PH; Uher R; Mors O
J Affect Disord; 2015 Sep; 183():287-94. PubMed ID: 26047306
[TBL] [Abstract][Full Text] [Related]
4. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
5. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation.
Giese M; Beck J; Brand S; Muheim F; Hemmeter U; Hatzinger M; Holsboer-Trachsler E; Eckert A
J Psychiatr Res; 2014 Dec; 59():1-7. PubMed ID: 25258340
[TBL] [Abstract][Full Text] [Related]
6. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
Gorgulu Y; Caliyurt O
Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
[TBL] [Abstract][Full Text] [Related]
7. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
[TBL] [Abstract][Full Text] [Related]
8. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
Zimmerman M; Walsh E; Chelminski I; Dalrymple K
J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
[TBL] [Abstract][Full Text] [Related]
9. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants.
Lee HY; Kim YK
Neuropsychobiology; 2008; 57(4):194-9. PubMed ID: 18679038
[TBL] [Abstract][Full Text] [Related]
10. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
[No Abstract] [Full Text] [Related]
11. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
[TBL] [Abstract][Full Text] [Related]
12. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
Shimizu E; Hashimoto K; Okamura N; Koike K; Komatsu N; Kumakiri C; Nakazato M; Watanabe H; Shinoda N; Okada S; Iyo M
Biol Psychiatry; 2003 Jul; 54(1):70-5. PubMed ID: 12842310
[TBL] [Abstract][Full Text] [Related]
13. Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study.
Halmai Z; Dome P; Dobos J; Gonda X; Szekely A; Sasvari-Szekely M; Faludi G; Lazary J
J Affect Disord; 2013 Jan; 144(3):269-73. PubMed ID: 23021824
[TBL] [Abstract][Full Text] [Related]
14. VEGF plasma level variations in duloxetine-treated patients with major depression.
Fornaro M; Rocchi G; Escelsior A; Contini P; Ghio M; Colicchio S; De Berardis D; Amore M; Fornaro P; Martino M
J Affect Disord; 2013 Nov; 151(2):590-595. PubMed ID: 23871390
[TBL] [Abstract][Full Text] [Related]
15. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
Shi Y; Luan D; Song R; Zhang Z
Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
[TBL] [Abstract][Full Text] [Related]
16. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
Huang TL; Lee CT; Liu YL
J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.
Machado-Vieira R; Yuan P; Brutsche N; DiazGranados N; Luckenbaugh D; Manji HK; Zarate CA
J Clin Psychiatry; 2009 Dec; 70(12):1662-6. PubMed ID: 19744406
[TBL] [Abstract][Full Text] [Related]
19. Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis.
Wang M; Zhang B; Zhou Y; Wang C; Zheng W; Liu W; Zhan Y; Lan X; Ning Y
Pharmacol Rep; 2021 Apr; 73(2):594-603. PubMed ID: 33387333
[TBL] [Abstract][Full Text] [Related]
20. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
